A new CSP position was established today on Novartis (NVS). All prices include IB commissions.
This is the second position on NVS.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $71.00 |
| Target Buy Price | $56.80 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $55.00 |
| Actual Margin of Safety | 20.29% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 2/22/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 55.00 | ($5,500.00) | ||
| 2/22/2012 | NVS | Initial Put Option | STO 1 Mar12 55.00 Put @ 0.79 | $78.97 |
Position Summary
| Cost Basis | ($5,500.00) |
| Income Generated | $78.97 |
| Percent Income Generated | 1.44% |
| Annualized Income Generated | 22.79% |
| Net Profit If Assigned | $78.97 |
| Percent Return If Assigned | 1.44% |
| Annualized Return If Assigned | 22.79% |
| Days Held to Expiration | 23 days |
